Why Amgen Is Down Nearly 7% Today

·2-min read
Why Amgen Is Down Nearly 7% Today

The biopharma name cautioned shareholders that it's still suffering from a pandemic hangover, but investors should think bigger-picture.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting